Dominant-negative p53 mutations in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 42, Issue 6, 1999, Pages 1088-1092

  Han, Zuoning ^a   Boyle, David L ^a   Shi, Yan ^a   Green, Douglas R ^b   Firestein, Gary S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 6; LUCIFERASE; MESSENGER RNA; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DOMINANT GENE; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SITE DIRECTED MUTAGENESIS; SYNOVIOCYTE;

ARTHRITIS, RHEUMATOID; BCL-2-ASSOCIATED X PROTEIN; BETA-GALACTOSIDASE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; DNA, COMPLEMENTARY; EPIDERMIS; FIBROBLASTS; GENES, DOMINANT; GENES, P53; HUMANS; LUCIFERASES; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE; TRANSFECTION;

EID: 0033043022     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199906)42:6<1088::AID-ANR4>3.0.CO;2-E     Document Type: Article

References (20)

1. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 5th ed. Philadelphia: WB Saunders; 1996. p. 851-97.
2. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993;52 Suppl 1:S39-47.
3. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
4. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 1989;83:1267-76.
5. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 1997;94:10895-900.
6. Reme T, Travaglio A, Gueydon E, Adla L, Jorgensen C, Sany J. Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol 1998;111:353-8.
7. Beroud C, Verdier F, Soussi T. p53 gene mutation: software and database. Nucleic Acids Res 1996;24:147-50.
8. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-9.
9. Bonsing BA, Corver WE, Gorsira MC, van Vliet M, Oud PS, Cornelisse CJ, et al. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry. Cytometry 1997;28:11-24.
10. Santhanam U, Ray A, Sehgal PB. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A 1991;88:7605-9.
11. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
12. Imamura F, Aono H, Hasunuma T, Sumida T, Tateishi H, Maruo S, et al. Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum 1998;41:1979-86.
13. Firestein GS, Nguyen K, Aupperle K, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143-51.
14. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K. Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:442-9.
15. Nickels A, Selter H, Pfreundschuh M, Montenarh M, Koch B. Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment. Clin Pathol 1997;50:654-60.
16. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
17. Finucane DM, Bossy-Wetzel E, Cotter TG, Green DR. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL J Biol Chem 1999;274:2225-33.
18. Deckwerth TL, Elliott JL, Knudson CM, Johnson EM Jr, Snider WD, Korsmeyer SJ. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 1996; 17:401-11.
19. Aupperle KR, Boyle DL, Hendrix M, Zvaifler NJ, Barbosa M, Firestein GS. Regulation of synoviocyte proliferation, apoptosis, and invasiveness by the p53 tumor suppressor gene. Am J Pathol 1998;152:1091-8.
20. Singh D, Nazhat NB, Fairburn K, Sahinoglu T, Blake DR, Jones P. Electron spin resonance spectroscopic demonstration of the generation of reactive oxygen species by diseased synovial tissue following ex vivo hypoxia-reoxygenation. Ann Rheum Dis 1995;54:94-9.